共 406 条
[1]
Koo S-M(2017)Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist’s point of view Korean J Intern Med 32 600-610
[2]
Uh S-T(2021)New insights into the treatment of CTD-ILD Nat Rev Rheumatol 17 79-80
[3]
Wells AU(2020)Systemic sclerosis-associated interstitial lung disease Lancet Respir Med 8 304-320
[4]
Perelas A(2020)Rheumatoid arthritis–associated interstitial lung disease: current update on prevalence, risk factors, and pharmacologic treatment Curr Treat Options in Rheum 6 337-353
[5]
Silver RM(2019)Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung disease Rheumatology (Oxford, England) 58 567-79
[6]
Arrossi AV(2018)Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement Clin Exp Rheumatol 36 648-651
[7]
Highland KB(2019)Myositis-related interstitial lung diseases: diagnostic features, treatment, and complications Curr Treatm Opt Rheumatol 5 56-83
[8]
Huang S(2013)Significance of connective tissue diseases features in pulmonary fibrosis Eur Respir Rev 22 273-280
[9]
Kronzer VL(2015)An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features Eur Respir J 46 976-87
[10]
Dellaripa PF(2021)Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study Rheumatology (Oxford) 60 346-352